Additionally, further experiments in primates will be required to evaluate the roles of miR-155 in improving glucose tolerance and insulin sensitivity, and subsequently lowering blood glucose levels, which will be helpful investigations in assessing the prospects for therapeutical miR-155 gain of function by using miR-155 mimics to treat insulin resistance and T2DM. This evidence concerns the gene INS and type 2 diabetes mellitus.